🔎 Trials Near Me

Početna › Debljina › Virginia › Arlington

Kliničke studije za Debljina u gradu Arlington, VA

18 studija za Debljina traži sudionike na lokacijama u gradu Arlington i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 2
  • Washington Center For Weight Management And Research /ID# 282047, Arlington
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

U tijeku regrutacijaFaza 2
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi udaljenosti
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

U tijeku regrutacijaFaza 3
  • Washington Cntr Weight Mgmt, Arlington
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07720271

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

U tijeku regrutacijaFaza 3
  • Research Site, Manassas · 22 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07776509

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

U tijeku regrutacijaFaza 3
  • Washington Cntr Weight Mgmt, Arlington
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07339423

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Research Site, Manassas · 22 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • Virginia Heart, Falls Church · 4 mi udaljenosti
  • Inova Cardiology - Fairfax, Fairfax · 11 mi udaljenosti
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

U tijeku regrutacijaFaza 3
  • Conquest Research, LLC, Arlington
  • Virginia Heart, Falls Church · 4 mi udaljenosti
  • Carient Heart and Vascular, Manassas · 22 mi udaljenosti
Od 18 do 99 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Manassas Clinical Research Center, Manassas · 22 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
  • ACCOMPLISH-2 Research Site, Burke · 11 mi udaljenosti
  • ACCOMPLISH-2 Research Site, Manassas · 22 mi udaljenosti
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

U tijeku regrutacijaFaza 3
  • Kailera Clinical Site, Manassas · 22 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

U tijeku regrutacijaFaza 3
  • Washington Center for Weight Management and Research, Inc, Arlington
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

U tijeku regrutacijaFaza 3
  • Manassas Clinical Research Center Inc, Manassas · 22 mi udaljenosti
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

U tijeku regrutacijaFaza 3
  • Kailera Clinical Site, Manassas · 22 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

U tijeku regrutacijaFaza 3
  • Research Site, Arlington
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

U tijeku regrutacijaFaza 3
  • Conquest Research, Vienna · 9 mi udaljenosti
  • Carient Heart and Vascular, Manassas · 22 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07567001

Brief Inhibitory Training for Eating - Intervention

U tijeku regrutacija
  • George Mason University, Fairfax · 11 mi udaljenosti
Od 14 do 17 godina · Oba spola · Ažurirano 17. lip 2026. · NCT07592728

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
  • Vanda Investigational Site, Burke · 11 mi udaljenosti
Od 18 do 65 godina · Oba spola · Ažurirano 20. tra 2026. · NCT07446439

Studije za Debljina u drugim gradovima

Ostale studije u gradu Arlington

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.